drugset

drugset / Trial / NCT02157012

Evaluation of the Condition of Rheumatoid Arthritis After Treatment

NCT02157012 ↗

Phase 4 Unknown 100 enrolled Shinshu University Showa Inan General Hospital · collab

NaSingle-groupOpen-labelTreatment

Summary

To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients

Timeline

Start: 2014-05
Primary completion: 2022-04
Completion: 2025-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tofacitinib	Small molecule	—	—

Indications